FI920323L - Nadh och nadph som energisubstitut. - Google Patents

Nadh och nadph som energisubstitut. Download PDF

Info

Publication number
FI920323L
FI920323L FI920323A FI920323A FI920323L FI 920323 L FI920323 L FI 920323L FI 920323 A FI920323 A FI 920323A FI 920323 A FI920323 A FI 920323A FI 920323 L FI920323 L FI 920323L
Authority
FI
Finland
Prior art keywords
som
nadh
nadph
och
energy substitute
Prior art date
Application number
FI920323A
Other languages
English (en)
Finnish (fi)
Other versions
FI920323A7 (fi
FI920323A0 (fi
Inventor
Joerg Birkmayer
Walther Birkmayer
Original Assignee
Joerg Birkmayer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joerg Birkmayer filed Critical Joerg Birkmayer
Publication of FI920323A0 publication Critical patent/FI920323A0/fi
Publication of FI920323A7 publication Critical patent/FI920323A7/fi
Publication of FI920323L publication Critical patent/FI920323L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Animal Husbandry (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
FI920323A 1991-01-24 1992-01-24 Nadh och nadph som energisubstitut. FI920323L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (cg-RX-API-DMAC7.html) 1991-01-24 1991-01-24

Publications (3)

Publication Number Publication Date
FI920323A0 FI920323A0 (fi) 1992-01-24
FI920323A7 FI920323A7 (fi) 1992-07-25
FI920323L true FI920323L (fi) 1992-07-25

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920323A FI920323L (fi) 1991-01-24 1992-01-24 Nadh och nadph som energisubstitut.

Country Status (14)

Country Link
EP (1) EP0496479B1 (cg-RX-API-DMAC7.html)
JP (1) JP2533709B2 (cg-RX-API-DMAC7.html)
AT (1) ATE112664T1 (cg-RX-API-DMAC7.html)
AU (1) AU663479B2 (cg-RX-API-DMAC7.html)
BR (1) BR9200207A (cg-RX-API-DMAC7.html)
CA (1) CA2059510C (cg-RX-API-DMAC7.html)
DE (2) DE4102240C1 (cg-RX-API-DMAC7.html)
DK (1) DK0496479T3 (cg-RX-API-DMAC7.html)
ES (1) ES2061313T3 (cg-RX-API-DMAC7.html)
FI (1) FI920323L (cg-RX-API-DMAC7.html)
HU (1) HU9200213D0 (cg-RX-API-DMAC7.html)
IE (1) IE69861B1 (cg-RX-API-DMAC7.html)
NO (1) NO304672B1 (cg-RX-API-DMAC7.html)
ZA (1) ZA92275B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2167104A1 (en) * 1995-01-17 1996-07-18 Joerg G.D. Birkmayer Nadh and nadph therapeutic agents for nasal, sublingual, rectal and dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
IT1318565B1 (it) * 2000-06-09 2003-08-27 World Pharma Tech Ltd Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (de) * 2008-02-20 2011-02-10 Emag Holding Gmbh Verfahren zum Schleifen wellenförmiger Werkstücke
DE102014103443A1 (de) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit
WO2020021734A1 (ja) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 機能性鶏卵及びその生産方法
DE202022000567U1 (de) 2022-03-06 2022-03-16 Penta Phi Eg Liposomale Formulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2736103B2 (ja) * 1988-03-01 1998-04-02 ヴァルター・ビルクマイヤー パーキンソン症候群の治療用医薬、およびその製造方法
AT397201B (de) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels

Also Published As

Publication number Publication date
NO920315L (no) 1992-07-27
AU663479B2 (en) 1995-10-12
IE69861B1 (en) 1996-10-16
ZA92275B (en) 1992-12-30
FI920323A7 (fi) 1992-07-25
JPH05262652A (ja) 1993-10-12
FI920323A0 (fi) 1992-01-24
BR9200207A (pt) 1992-10-06
NO304672B1 (no) 1999-02-01
NO920315D0 (no) 1992-01-23
JP2533709B2 (ja) 1996-09-11
HU9200213D0 (en) 1992-04-28
ES2061313T3 (es) 1994-12-01
EP0496479B1 (de) 1994-10-12
DE4102240C1 (cg-RX-API-DMAC7.html) 1992-04-09
CA2059510A1 (en) 1992-07-25
DE59200603D1 (de) 1994-11-17
EP0496479A1 (de) 1992-07-29
AU1039292A (en) 1992-07-30
CA2059510C (en) 1997-06-10
ATE112664T1 (de) 1994-10-15
DK0496479T3 (da) 1995-04-18
IE920198A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
FI910256A0 (fi) Foerfarande foer bestaemning av mikrobpatogener, som sprids med vatten, och fekala foeroreningar indikerande aemnen i vattenprov och testfoerpackning.
FI913738A7 (fi) Oximkarbamater och oximkarbonater som luftroersutvidgande och antiinflammatoriska aemnen.
NO901062D0 (no) Energiabsorberende konstruksjon.
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI915387A0 (fi) Tuggummi, som avger smak under en foerlaengd tidsperiod och som innehaoller omaettade, renade monoglycerider.
FI921952A0 (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel.
FI915719L (fi) Gallsyraderivat, foerfarande foer deras framstaellning och anvaendning av denna foerening som laekemedel.
FI925802L (fi) Hyaluronsyraderivat, som aer oloesliga i vatten
FI912634A0 (fi) Mineralfibrer som kan upploesas i fysiologiska omgivning.
FI914004L (fi) Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen.
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI923558A0 (fi) Tetrahydroindazol-, tetrahydrocyklo -pentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas.
FI921073L (fi) Kompositioner, vilka aer laempliga som bindemedel och skyddsbelaeggningarfoer tryckfaerger
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI911512L (fi) Oeverbasiska calixarater, foerfarande foer deras framstaellning, kompositioner innehaollande desamma och deras anvaendning som tillsatsaemnen i smoerjaemnen.
FI920342L (fi) Komplex som innehaoller koaguleringsfaktor ix och foerfarande foer framstaellning daerav.
FI913201A7 (fi) Ymppolysackarider, deras framställningsförfarande och deras användning som sekvesteringsagenter
FI914504A7 (fi) Substituerade 4-amino-3-pyridinoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI925151L (fi) Motstroemsvaetskor/vaetskeextraktion foer att fraktionera komplexblandningar, som innehaoller medium och laongkedjade fettsyratriglycerider
FI920323L (fi) Nadh och nadph som energisubstitut.
FI933654L (fi) Antiproliferativa och antiinflammatoriska foereningar:5- eller 6-deoxihexosmonosackarider med en kvaeve- innehaollande maettad heterocykel i 5- eller 6-staellning, som aer bunden via kvaeveatomen
FI921596A0 (fi) Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer.
FI923841A7 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI913657A7 (fi) 4-amino-d4-steroider och deras anvaendning som 5a-reduktasinhibitorer.
FI914556A0 (fi) 4- eller 5-substituerade pyridiner-2-karboxylsyror, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Legal Events

Date Code Title Description
FD Application lapsed